Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,864
Sort by:
Lung Cancer Therapeutics – A Global Market Overview
US$ 4,500.00
Lung Cancer Therapeutics Market Trends and Outlook Lung cancer, also known as lung carcinoma, is a malignant tumor that begins in the lungs and is caused by genetic damage to airway cells from smoking...
November 2024
254 pages
Breast Cancer Therapeutics – A Global Market Overview
US$ 4,500.00
Breast Cancer Therapeutics Market Trends and Outlook Breast cancer occurs when uncontrolled growth of cells in the breast leads to the formation of a tumor that can invade nearby tissues or spread to...
November 2024
257 pages
Cervical Cancer Treatment – A Global Market Overview
US$ 4,500.00
Cervical Cancer Treatment Market Trends and Outlook Cervical cancer develops in the cervix and is often associated with Human Papillomavirus (HPV) infections, progressing slowly and beginning with dys...
November 2024
250 pages
Global Oncology Pharmaceuticals Market
US$ 4,650.00
Report This report seeks to deliver an in-depth analysis of the worldwide oncology pharmaceuticals (cancer medications) market. It includes a thorough overview of various types of oncology drugs, such...
October 2024
181 pages
Global Lung Cancer Therapy Market: Analysis By Treatment Method (Non-Invasive and Minimally Invasive), By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, and Other Therapies), By Indication (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,450.00
The global lung cancer therapy market was valued at US$32.50 billion in 2023. The market value is expected to reach US$70.39 billion by 2029. Lung cancer therapy is a critical area of oncology, focusi...
September 2024
184 pages
Turkey Cancer Drugs Clinical Trials Insight 2024
US$ 3,300.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Turkey Cancer Drugs Clinical Trials Insight 2024 Report Offering:Turkey Clinical Trials M...
July 2024
500 pages
Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast, Prostate), Non-cancer (NIPT, Infectious)), Sample Type (Blood) - Global Forecast to 2029
US$ 3,217.50
... during the forecast period” Based on application, the liquid biopsy market is segmented into cancer and non-cancer applications (which include reproductive health and organ ...
May 2024
328 pages
Asia Pacific Breast Cancer Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies)
US$ 2,485.00
The Asia Pacific breast cancer therapeutics market was valued at US$ 6,986.37 million in 2022 and is expected to reach US$ 15,819.83 million by 2030; it is estimated to grow at a CAGR of 10.8% from 20...
March 2024
106 pages
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]) Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031
US$ 2,922.00
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospita...
February 2024
209 pages
Multi-Cancer Diagnostic Tests: Global Market Outlook
US$ 2,950.00
Report : The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and chal...
February 2024
50 pages
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
US$ 4,650.00
The global market for prostate cancer products reached nearly $47.2 billion in 2016 and should reach nearly $65.1 billion in ... should reach $27.4 billion in 2021, with a CAGR of 7.2 %. Surgical and radiation therapy as a segment reached nearly $14.4 billion in 2016 and should reach $20.8 billion ...
January 2024
157 pages
Global Gastric Cancer Diagnostic Market: Analysis By Product Type (Reagents and Consumables and Instruments), By Disease Type (Adenocarcinoma, Gastric Lymphoma and Others), By End User (Hospitals, Oncology Specialty Clinics, Diagnostic Labs, Cancer Research Institutes And Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
US$ 2,250.00
Gastric cancer diagnostic involves a comprehensive process of identifying stomach cancer through clinical evaluation, imaging studies like endoscopy and CT scans, biopsy for tissue examination, and bl...
January 2024
143 pages
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...
November 2023
300 pages
Cancer Diagnostic Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...
November 2023
450 pages
Oncology Collaboration and Licensing Deals 2019-2023
US$ 3,995.00
... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...
October 2023
1600 pages
Testicular Cancer Drugs Market Report by Type of Cancer (Seminoma, Non-Seminoma), Drug Type (Cisplatin, Etoposide, Ifosfamide, Vinblastine, Bleomycin, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2023-2028
US$ 2,249.00
Market Overview: The global testicular cancer drugs market size reached US$ 653.24 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 884.84 Million by 2028, exhibiting a g...
September 2023
147 pages
Global Cervical Cancer Therapeutics Market 2023
US$ 3,350.00
The global cervical cancer therapeutics market was valued at USD 5.66 billion in 2022 and is projected to reach USD 7.14 billion by 2029, exhibiting a compound annual growth rate of 3.3% between 2023...
September 2023
94 pages
Pancreatic Cancer Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type {Diagnostic Imaging Tests (CT scan, MRI, Ultrasound, Others), Biopsy, Blood Tests, Liver Function Tests, Others}, By Cancer Type (Exocrine, Adenocarcinoma, Squamous Cell Carcinoma, Colloid Carcinoma, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), Region and Competition
US$ 4,500.00
Global Pancreatic Cancer Diagnostics Market is poised to grow at an impressive rate during the forecast period on account of the increasing incidence of pancreatic cancer, rising demand for minimally...
August 2023
113 pages
Oncology Biomarkers: Global Markets
US$ 4,650.00
Report : This study provides a comprehensive analysis of oncology biomarkers on a global basis. It aims to offer a range of information, from detailed market analyses within cancer types to overall in...
June 2023
186 pages
Multicancer Screening Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample, Method, Cancer Type, Application, End User, and Region Analysis - Analysis and Forecast, 2023-2032
US$ 5,500.00
Global Multicancer Screening Market Industry Overview The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during...
April 2023
228 pages
Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
US$ 4,950.00
... various cancer/tumor profiling technologies and their adoption pattern. It aims at estimating the market size and future growth potential of cancer/tumor profiling market and the different segments such as by technology, cancer ...
November 2022
295 pages
Interventional Oncology Global Market - Forecast To 2029
US$ 4,950.00
Interventional Oncology (IO) is a rapidly growing field in cancer care that uses minimally invasive procedures performed under image guidance to diagnose and treat patients with liver, kidney, lung, B...
September 2022
378 pages
Head and Neck Cancer Therapeutics: Global Markets
US$ 5,500.00
Report : This report aims to provide a comprehensive study of the global market for head and neck cancer therapeutics, both in terms of quantitative and qualitative data, to help businesses develop gr...
August 2022
148 pages
RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), End User (Pharma, Payer) - Global Forecast to 2029
US$ 2,922.00
RWE Oncology Solutions Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillanc...
July 2022
200 pages
Monoclonal Antibodies for Oncology: Global Markets
US$ 5,500.00
Report : The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies...
June 2022
124 pages
Cancer Supportive Care Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (G-CSFs, ESAs, Opioids), By Region (APAC, North America, Europe, MEA), And Segment Forecasts, 2022 - 2030
US$ 5,950.00
... to drive growth of the global cancer supportive care drugs market. High efficiency of these drugs in controlling the adverse effects of cancer and its treatment is projected ... major brands such as Epogen North America led the cancer supportive care drugs market in 2018 and is expected to maintain its position ...
May 2022
89 pages
